Latest From Our Blog
Nov
04
(New York Times 7/11). A combination of factors has discouraged many doctors from carrying Zostavax, the vaccine for shingles. Merck, the manufacturer has also been unable to provide sufficient quantities to even meet modest demands. As a result, intermittent shortages have prevented consistent marketing and have therefore stalled Public Health agencies from informing the public. […]
